| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | Director | $43.4M | Dec 24, 2024 | ||
| Aharon Gil | Director | $43.4M | Dec 24, 2024 | ||
| Steven Salamon | Director | $43.4M | Dec 24, 2024 | ||
| Gerard J. Michel | CHIEF EXECUTIVE OFFICER, Director | $1.92M | Feb 7, 2025 | ||
| Vojo Vukovic | Chief Medical Officer | $472K | Feb 7, 2025 | ||
| David Hoffman | Gen'l Counsel, Cco & Secy | $277K | Feb 7, 2025 | ||
| Sandra Pennell | Chief Financial Officer | $227K | Feb 7, 2025 | ||
| John Purpura | Chief Operating Officer | $125K | Feb 8, 2023 | ||
| Kevin Muir | Gm Interventional Oncology | $69.1K | Feb 7, 2025 | ||
| John Richard Sylvester | Director | $31.7K | May 23, 2024 | ||
| Johnny John | Svp Clinical Dev & Med Affairs | Feb 8, 2023 | |||
| Martha S. Rook | Chief Operating Officer | Feb 7, 2025 | |||
| Christine Padula | Interim Principal Accounting Officer | Sep 1, 2021 | |||
| Bridget Martell | Director | May 23, 2024 | |||
| Roger G. Stoll Phd | Director | May 23, 2024 | |||
| Elizabeth Czerepak | Director | May 23, 2024 | |||
| Anthony Dias | Vp Finance | Feb 8, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|